Literature DB >> 2551628

Characterization of tumor necrosis factor-alpha receptors in human and rat thyroid cells and regulation of the receptors by thyrotropin.

X P Pang1, J M Hershman, M Chung, A E Pekary.   

Abstract

Administration of recombinant human tumor necrosis factor-alpha (TNF) to rats and mice produces a model of nonthyroid illness in which there is impairment of hypothalamic-pituitary thyroid function, including reduced serum concentrations of T4 and T3, reduced thyroid radioiodine uptake, and reduced response to TSH. In this study, we tested the binding and effects of TNF on FRTL-5 cells and on four human thyroid carcinoma cell lines. The TSH-stimulated [125I]iodide uptake by FRTL-5 cells was inhibited by TNF in a dose-dependent manner. The four human thyroid carcinoma cell lines (NPA, MRO, ARO, WRO) have TSH receptors but did not respond to TSH in regard to iodide uptake and thymidine incorporation. Both human thyroid carcinoma cells and FRTL-5 cells contain specific receptors for TNF. Scatchard analysis showed that the receptor numbers and dissociation constants in human thyroid carcinoma cells and FRTL-5 cells were, respectively; 2.4 x 10(4), 5.4 nM (WRO); 8 x 10(3), 3.4 nM (MRO); 4 x 10(3), 1 nM (ARO); 7 x 10(3), 1 nM (NPA); 3 x 10(3), 1 nM (FRTL-5), and 9 x 10(3), 1 nM (FRTL-5 cells treated with TSH). The results indicate that TNF affects thyroid cell function through binding to the TNF receptor and that the number of TNF receptors is regulated by TSH.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2551628     DOI: 10.1210/endo-125-4-1783

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  32 in total

Review 1.  Euthyroid Sick Syndrome and the role of cytokines.

Authors:  D A Papanicolaou
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

2.  A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression.

Authors:  Janete M Cerutti; Rosana Delcelo; Marcelo João Amadei; Claudia Nakabashi; Rui M B Maciel; Bercedis Peterson; Jennifer Shoemaker; Gregory J Riggins
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

3.  The effects of hormones of the hypothalamo-hypophyseal-adrenal, renin-angiotensin, and thyroid hormone systems on the formation of dyscirculatory encephalopathy.

Authors:  V I Skvortsova; I A Platonova; T V Tvorogova; O V Volkovenko; L I Demidova; I V Ostrovtsev
Journal:  Neurosci Behav Physiol       Date:  2004-11

Review 4.  The immune system as a regulator of thyroid hormone activity.

Authors:  John R Klein
Journal:  Exp Biol Med (Maywood)       Date:  2006-03

5.  "Thyroid cancer" cell line misidentification: a time for proactive change.

Authors:  Matthew D Ringel
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

Review 6.  Thyroid dysfunction from antineoplastic agents.

Authors:  Ole-Petter Riksfjord Hamnvik; P Reed Larsen; Ellen Marqusee
Journal:  J Natl Cancer Inst       Date:  2011-10-18       Impact factor: 13.506

7.  Thyrotropin modifies activation of nuclear factor kappaB by tumour necrosis factor alpha in rat thyroid cell line.

Authors:  T Kikumori; F Kambe; T Nagaya; H Funahashi; H Seo
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

8.  A dimeric mutant of human pancreatic ribonuclease with selective cytotoxicity toward malignant cells.

Authors:  R Piccoli; S Di Gaetano; C De Lorenzo; M Grauso; C Monaco; D Spalletti-Cernia; P Laccetti; J Cinátl; J Matousek; G D'Alessio
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

9.  Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action.

Authors:  K S Banu; P Govindarajulu; M M Aruldhas
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

10.  Leptin, thyrotropin, and thyroid hormones in obese/overweight women before and after two levels of energy deficit.

Authors:  Lucyna Kozłowska; Danuta Rosołowska-Huszcz
Journal:  Endocrine       Date:  2004-07       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.